Pharmaceuticals, Biotechnology and Life Sciences
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH…
Complementary Technologies, Customer Bases, and Commercial Channels to Strengthen Leadership in High-Growth, Single-Cell Biology Significant Cost Synergies to Increase Profitability…
Company Intends to Hold FY 2022 Annual Meeting in February 2023NEW YORK, Dec. 21, 2022 (GLOBE NEWSWIRE) — Intelligent Bio…
LX9211.202 ADPS Results: Separation from Placebo Was Seen by Week 1 in LX9211 Treatment Arm and Continued to Week 6…
WOODCLIFF LAKE, N.J., Dec. 21, 2022 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced…
$259 Million in Equity Securities Sales and $50 Million in Additional Debt Financing CapacityMadrigal intends to submit a new drug…
PARIS and CAMBRIDGE, Mass., Dec. 21, 2022 (GLOBE NEWSWIRE) — NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a…
PURCHASE, N.Y., Dec. 21, 2022 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc. (Nasdaq: CGTX) (the “Company” or “Cognition”), announced today that…
Eledon to Incorporate the iBox Scoring System in Future Kidney Transplant TrialsIRVINE, Calif., Dec. 21, 2022 (GLOBE NEWSWIRE) — Critical…
Results of the main study in patients with compensated cirrhosis due to NASH (F4) expected in fourth quarter of 2023…